Nancy Simonian
2023
In 2023, Nancy Simonian earned a total compensation of $1.4M as Former President & Chief Executive Officer at Syros Pharmaceuticals, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,986 |
|---|---|
| Salary | $635,385 |
| Stock Awards | $477,174 |
| Other | $5,237 |
| Total | $1,436,782 |
Simonian received $635.4K in salary, accounting for 44% of the total pay in 2023.
Simonian also received $319K in non-equity incentive plan, $477.2K in stock awards and $5.2K in other compensation.
Rankings
In 2023, Nancy Simonian's compensation ranked 759th out of 2,311 executives tracked by ExecPay. In other words, Simonian earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 759 out of 2,311 | 67th |
Division Manufacturing | 436 out of 1,247 | 65th |
Major group Chemicals And Allied Products | 298 out of 705 | 58th |
Industry group Drugs | 291 out of 676 | 57th |
Industry Pharmaceutical Preparations | 197 out of 490 | 60th |
Source: SEC filing on April 23, 2024.
Simonian's colleagues
We found one more compensation record of an executive who worked with Nancy Simonian at Syros Pharmaceuticals in 2023.
2023
Eric Olson
Syros Pharmaceuticals
Chief Scientific Officer
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019